Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 1

Did we overcome rheumatic heart disease or is it still a public disease burden?

Pages
186–190
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Transthoracic echocardiography may be helpful in detecting RHD at the early-stages and preventing progression of the disease with secondary antibiotic prophylaxis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Rheumatic heart disease (RHD), affecting approximately 32 million people all over the world is one of the major causes of cardiovascular morbidity and mortality especially in developing countries.
📊
Key Findings & Data:A total of 386 healthy young individuals (45 female, 341 males) who applied to our Cardiology Clinic for being military personnel coming from different regions of Turkey in the year 2015, were recruited for our study. 2012 World Heart Federation (WHF) criteria for echocardiographic assessment and diagnosis of RHD were used.
💡
Conclusion & Impact:Transthoracic echocardiography may be helpful in detecting RHD at the early-stages and preventing progression of the disease with secondary antibiotic prophylaxis.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Rheumatic heart disease (RHD), affecting approximately 32 million people all over the world is one of the major causes of cardiovascular morbidity and mortality especially in developing countries. In this ongoing pilot study, we aim to investigate the prevalence of both definitive and borderline RHD in Turkey as a developing country. A total of 386 healthy young individuals (45 female, 341 males) who applied to our Cardiology Clinic for being military personnel coming from different regions of Turkey in the year 2015, were recruited for our study. 2012 World Heart Federation (WHF) criteria for echocardiographic assessment and diagnosis of RHD were used. Study population was classified into one of the three groups as normal, borderline RHD and definitive RHD. The three groups were similar in terms of baseline characteristics and laboratory findings. Definitive and borderline RHD were found in 11 (2,9%) and 29 (7,5%) individuals, respectively. Abnormal thickening of the anterior mitral valve leaflet (AMVL) was found statistically significant between the normal and the RHD groups (3.1±0.6 vs 4.2±0.9, p<0.001). Even though the number of patients in our study is small, we found the incidence of borderline and the definitive RHD higher than we expected. Transthoracic echocardiography may be helpful in detecting RHD at the early-stages and preventing progression of the disease with secondary antibiotic prophylaxis.

🔖

Cite This Article

YILDIRIM, E., BUĞAN, B. (2018). Did we overcome rheumatic heart disease or is it still a public disease burden?. Medicine Science, Cilt: 7 - Sayı: 1, 186–190. https://ajindex.com/articles/277218

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet.2015; 386(9995):743-800.
  2. Mirabel M, Fauchier T, Bacquelin R, Tafflet M, Germain A, Robillard C, Rouchon B, Marijon E, Jouven X. Echocardiography screening to detect rheumatic heart disease: a cohort study of schoolchildren in French Pacific Islands, Int. J. Cardiol. 2015;188: 89–95.
  3. Roberts K, Maguire G, Brown A, Atkinson D, Remenyi B, Wheaton G, Kelly A, Kumar RK, Su JY, Carapetis JR. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children, Circulation. 2014;129(19):1953–61.
  4. Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart. 2005;91(8):1019-22.
  5. Carapetis JR, Kilburn CJ, MacDonald KT, Walker AR, Currie JB. Tenyear follow up of a cohort with rheumatic heart disease (RHD). Aust N Z J Med.1997;27(6):691-7.
  6. Carapetis JR, Zühlke LJ. Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol. 2011;4(1):4-12.
  7. Zhang W, Mondo C, Okello E, Musoke C, Kakande B, Nyakoojo W, Kayima J, Freers J. Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study. Cardiovasc J Afr. 2013;24(2):28-33.
  8. Akinwusi PO, Peter JO, Oyedeji AT, Odeyemi AO. The new face of rheumatic heart disease in South West Nigeria. Int J Gen Med 2013;6:375-81. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabel M, Mocumbi AO, Mota C, Paar J, Saxena A, Scheel J, Stirling J, Viali S, Balekundri VI, Wheaton G, Zühlke L, Carapetis J. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline Nat Rev Cardiol. 2012;28;9:297-309.
  9. Wallace MR, Garst PD, Papadimos TJ, Oldfield EC 3rd. The return of acute rheumatic fever in young adults. JAMA. 1989;262(18):2557–61. Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, Damorou JM, Ndobo P, Menanga A, Kane A, Kakou-Guikahué M, Kenfack M, Metogo B, Chelo D, Yangnigni E, Tantchou C, Bertrand E, Monsuez JJ; Working Group on Tropical Cardiology of the Société française de cardiologie.The VALVAFRIC study:A registry of r